A role for mammalian target of rapamycin (mTOR) pathway in non alcoholic steatohepatitis related-cirrhosis

Histology and Histopathology

Volumn 25, Issue 9, 2010, Pages 1123-1131

  Kubrusly, Márcia Saldanha ^a   Corrêa Giannella, Maria Lúcia ^a   Bellodi Privato, Marta ^a   De Sá, Sandra Valéria ^a   Souza De Oliveira, Claudia Pinto Marques ^a   Soares, Iberê Cauduro ^a   Wakamatsu, Alda ^a   Alves, Venâncio Avancini Ferreira ^a   Giannella Neto, Daniel ^a   Bacchella, Telesforo ^a   Machado, Marcel Cerqueira Cesar ^a   D'Albuquerque, Luiz Augusto Carneiro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cirrhosis; Gene expression profile; Microarray analysis; MTOR pathway; Non alcoholic steatohepatitis

Indexed keywords

MAMMALIA;

BIOLOGICAL MARKER; EIF4EBP1 PROTEIN, HUMAN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; BIOSYNTHESIS; DNA MICROARRAY; FATTY LIVER; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; TISSUE MICROARRAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BIOLOGICAL MARKERS; FATTY LIVER; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; TISSUE ARRAY ANALYSIS;

EID: 77957336340     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ashburner M., Ball C. A., Blake J. A., Botstein D., Butler H., Cherry J. M., Davis A. P., Dolinski K., Dwight S. S., Eppig J. T., Harris M. A., Hill D. P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J. C., Richardson J. E., Ringwald M., Rubin G. M. and Sherlock G. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29.
2. Assy N., Bekirov I., Mejritsky Y., Solomon L., Szvalb S. and Hussein O. (2005). Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases. World J. Gastroenterol. 11, 5834-5839.
3. Boisvert J., Kunkel E. J., Campbell J. J., Keeffe E. B., Butcher E. C. and Greenberg H. B. (2003). Liver-infiltrating lymphocytes in end-stage hepatitis C virus: Subsets, activation status, and chemokine receptor phenotypes. J. Hepatol. 38, 67-75.
4. Bugianesi E., Leone N., Vanni E., Marchesini G., Brunello F., Carucci P., Musso A., De Paolis P., Capussotti L., Salizzoni M. and Rizzetto M. (2002). Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123, 134-140.
5. Caldwell S. H. and Hespenheide E. E. (2002). Subacute liver failure in obese women. Am. J. Gastroenterol. 97, 2058-2062.
6. Calvert V. S., Collantes R., Elariny H., Afendy A., Baranova A., Mendoza M., Goodman Z., Liotta L. A., Petricoin E. F. and Younossi Z. M. (2007). A systems biology approach to the pathogenesis of obesityrelated nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology 46, 166-172.
7. Chiappini F., Barrier A., Saffroy R., Domart M. C., Dagues N., Azoulay D., Sebagh M., Franc B., Chevalier S., Debuire B., Dudoit S. and Lemoine A. (2006). Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab. Invest. 86, 154-165.
8. Fingar D. C. and Blenis J. (2004). Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23, 3151-3171.
9. Friedman S. L. (2003). Liver fibrosis - from bench to bedside. J. Hepatol. 8, S38-S53.
10. Harvey P. J., Gready J. E., Yin Z., Le Couteur D. G. and McLean A. J. (2000). Acute oxygen supplementation restores markers of hepatocyte energy status and hypoxia in cirrhotic rats. J. Pharm. Exp. Therap. 293, 641-645.
11. Hashimoto M., Kothary P. C., Eckhauser F. E. and Raper S. E. (1998). Treatment of cirrhotic rats with epidermal growth factor and insulin accelerates liver DNA synthesis after partial hepatectomy. J. Gastroenterol. Hepatol. 13, 1259-1265.
12. Herberger B., Puhalla H., Lehnert M., Wrba F., Novak S., Brandstetter A., Gruenberger B., Gruenberger T., Pirker R. and Filipits M. (2007). Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma. Clin. Cancer Res. 13, 4795-4799.
13. Khamzina L., Veilleux A., Bergeron S. and Marette A. (2005). Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: Possible involvement in obesitylinked insulin resistance. Endocrinology 146, 1473-1481.
14. Kim J. W., Ye Q., Forgues M., Chen Y., Budhu A., Sime J., Hofseth L. J., Kaul R. and Wang X. W. (2004). Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology 39, 518-527.
15. Kleiner D. E., Brunt E. M., Van Natta M., Behling C., Contos M. J., Cummings O. W., Ferrell L. D., Liu Y. C., Torbenson M. S., Unalp-Arida A., Yeh M., McCullough A. J. and Sanyal A. J. (2005). Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histologic scoring system for NAFLD. Hepatology 41, 1313-1321.
16. Kononen J., Bubendorf L., Kallioniemi A., Bärlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M. J., Sauter G. and Kallioniemi O. P. (1998). Tissue microarrays for high throughput molecular profiling of tumor specimens. Nat. Med. 4, 844-847.
17. Korsheninnikova E., van der Zon G. C., Voshol P. J., Janssen G. M., Havekes L. M., Grefhorst A., Kuipers F., Reijngoud D. J., Romijn J. A., Ouwens D. M. and Maassen J. A. (2006). Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. Diabetologia 49, 3049-3057.
18. Leong H. X., Simkevich C., Lesieur-Brooks A., Lau B. W., Fugere C., Sabo E. and Thompson N. L. (2006). Short-term arginine deprivation results in large-scale modulation of hepatic gene expression in both normal and tumor cells: microarray bioinformatic analysis. Nutrition Metabol. http://www.nutritionandmetabolism.com/content/3/1/37.
19. Marshall S. (2006). Role of insulin, adipocyte hormones, and nutrientsensing pathways in regulating fuel metabolism and energy homeostasis: A nutritional perspective of diabetes, obesity, and cancer. Sci STKE 346, re7.
20. McCullough A. J. (2002). Update on nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 34, 255-262.
21. Ong J., Younossi Z. M., Reddy V., Price L. L., Gramlich T., Mayes J. and Boparai N. (2001). Cryptogenic cirrhosis and post transplantation nonalcoholic fatty liver disease. Liver Transpl. 7, 797-801. (Pubitemid 32851301)
22. Ozcan U., Cao Q., Yilmaz E., Lee A. H., Iwakoshi N. N., Ozdelen E., Tuncman G., Görgün C., Glimcher L. H. and Hotamisligil G. S. (2004). Endoplasmic reticulum stress links obesity, insulin action, and type 2 Diabetes. Science 306, 457-461.
23. Parsons C. J., Takashima M. and Rippe R. A. (2007). Molecular mechanisms of hepatic fibrogenesis. J. Gastroenterol. Hepatol. 22, S79-S84.
24. Pinzani M. and Marra F. (2001). Cytokine receptors and signaling in hepatic stellate cells. Sem. Liver Dis. 21, 397-416.
25. Reiner A., Yekutieli D. and Benjamini Y. (2003). Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19, 368-375.
26. Shackel N. A., McGuinness P. H., Abbott C. A., Gorrell M. D. and McCaughan G. W. (2003). Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization. Hepatology 38, 577-588.
27. Shi S. R., Key M. E. and Kalra K. L. (1991). Antigen retrieval in formalinfixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based upon microwave oven heating of tissue sections. J. Histochem. Cytochem. 39, 741-748.
28. Smith M. W., Yue Z. N., Korth M. J., Do H. A., Boix L., Fausto N., Bruix J., Carithers R. L. Jr and Katze M. G. (2003). Hepatitis C virus and liver disease: Global transcriptional profiling and identification of potential markers. Hepatology 38, 1458-1467.
29. Sreekumar R., Rosado B., Rasmussen D. and Charlton M. (2003). Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology 38, 244-251.
30. Yang Q. and Guan K. L. (2007). Expanding mTOR signaling. Cell. Res. 177, 666-681.
31. Younossi Z. M., Baranova A., Ziegler K., Del Giacco L., Schlauch K., Born T. L., Elariny H., Gorreta F., VanMeter A., Younoszai A., Ong J. P., Goodman Z. and Chandhoke V. (2005). A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology 42, 665-674. (Pubitemid 41233660)